中国类风湿关节炎患者报告的临床结局量表专家共识

2018-05-20 中华中医药学会 中医杂志.2018,59(10):897-900.

中国中医科学院广安门医院风湿病团队课题组前期通过借助中国中医科学院刘保延教授“国家科技部基础平台建设项目( 2004DEA71040) ”研究,在多家医疗机构中西医临床专家及方法学、统计学、流行病学等多学科专家的共同参与下,开展了大量基于中医问诊的RA-PRO 量表开发工作。依据量表的方法学原理,经过文献阅读、病历回顾、患者访谈、专家咨询等方法初步构建了“类风湿关节炎患者报告的临床结局测量量表”,

中文标题:

中国类风湿关节炎患者报告的临床结局量表专家共识

发布机构:

中华中医药学会

发布日期:

2018-05-20

简要介绍:

中国中医科学院广安门医院风湿病团队课题组前期通过借助中国中医科学院刘保延教授“国家科技部基础平台建设项目( 2004DEA71040) ”研究,在多家医疗机构中西医临床专家及方法学、统计学、流行病学等多学科专家的共同参与下,开展了大量基于中医问诊的RA-PRO 量表开发工作。依据量表的方法学原理,经过文献阅读、病历回顾、患者访谈、专家咨询等方法初步构建了“类风湿关节炎患者报告的临床结局测量量表”,原量表包含4 个维度、16 条目,每一条目分为4 个等级。
 
拓展指南:类风湿关节炎相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国类风湿关节炎患者报告的临床结局量表专家共识)] GetToolGuiderByIdResponse(projectId=1, id=0251b1c00159608e, title=中国类风湿关节炎患者报告的临床结局量表专家共识, enTitle=, guiderFrom=中医杂志.2018,59(10):897-900., authorId=null, author=, summary=中国中医科学院广安门医院风湿病团队课题组前期通过借助中国中医科学院刘保延教授“国家科技部基础平台建设项目( 2004DEA71040) ”研究,在多家医疗机构中西医临床专家及方法学、统计学、流行病学等多学科专家的共同参与下,开展了大量基于中医问诊的RA-PRO 量表开发工作。依据量表的方法学原理,经过文献阅读、病历回顾、患者访谈、专家咨询等方法初步构建了“类风湿关节炎患者报告的临床结局测量量表”,, cover=, journalId=null, articlesId=null, associationId=1659, associationName=中华中医药学会, associationIntro=, copyright=0, guiderPublishedTime=Sun May 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>中国中医科学院广安门医院风湿病团队课题组前期通过借助中国中医科学院刘保延教授“国家科技部基础平台建设项目( 2004DEA71040) ”研究,在多家医疗机构中西医临床专家及方法学、统计学、流行病学等多学科专家的共同参与下,开展了大量基于中医问诊的RA-PRO 量表开发工作。依据量表的方法学原理,经过文献阅读、病历回顾、患者访谈、专家咨询等方法初步构建了“类风湿关节炎患者报告的临床结局测量量表”,原量表包含4 个维度、16 条目,每一条目分为4 个等级。</div> <div> </div>拓展指南:<strong>与<font color="red">类风湿关节炎</font>相关指南:</strong><br><ul><li><a title="2018中国类风湿关节炎诊疗指南" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=396561c0015e72b0">2018中国类风湿关节炎诊疗指南</a></li> <li><a title="2014 类风湿关节炎患者的慢病管理专家共识" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=24d691c001269661">2014 类风湿关节炎患者的慢病管理专家共识</a></li> <li><a title="2015年美国风湿病学会类风湿关节炎的治疗指南" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=7aa841c001165e8b">2015年美国风湿病学会类风湿关节炎的治疗指南</a></li> <li><a title="风湿免疫疾病( 类风湿关节炎) 超药品说明书用药专家共识" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=21a981c00111a3c1">风湿免疫疾病( 类风湿关节炎) 超药品说明书用药专家共识</a></li> <li><a title="2013 托珠单抗治疗类风湿关节炎的专家建议" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=7e7b51c00100209e">2013 托珠单抗治疗类风湿关节炎的专家建议</a></li> 更多信息请点击:<a target="_blank" href="http://www.medsci.cn/guideline/list.do?q=%E7%B1%BB%E9%A3%8E%E6%B9%BF%E5%85%B3%E8%8A%82%E7%82%8E">有关类风湿关节炎更多指南</a></ul>, tagList=[TagDto(tagId=457, tagName=类风湿关节炎), TagDto(tagId=75465, tagName=临床结局量表)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8149, appHits=378, showAppHits=0, pcHits=6069, showPcHits=2704, likes=128, shares=18, comments=13, approvalStatus=1, publishedTime=Fri May 25 22:40:06 CST 2018, publishedTimeString=2018-05-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri May 25 22:40:06 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 05:39:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国类风湿关节炎患者报告的临床结局量表专家共识)])
中国类风湿关节炎患者报告的临床结局量表专家共识
下载请点击:
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2142249, encodeId=615d2142249b5, content=这个量表用起来方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22b81526605, createdName=wyh20044002, createdTime=Sun Jun 11 20:57:08 CST 2023, time=2023-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=379039, encodeId=b2ba3e903992, content=学习学习,感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a675276231, createdName=14832c09m20暂无昵称, createdTime=Sun Feb 09 00:10:51 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379038, encodeId=4b7d3e90389c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a675276231, createdName=14832c09m20暂无昵称, createdTime=Sun Feb 09 00:10:35 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360128, encodeId=60b2360128ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/3ca7e45a5a3a70cdf0a44fb6301db4ff.jpg, createdBy=aa512256377, createdName=121757d6m64(暂无昵称), createdTime=Thu Feb 07 12:36:47 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318706, encodeId=a376318e0656, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat May 26 09:39:46 CST 2018, time=2018-05-26, status=1, ipAttribution=)]
    2023-06-11 wyh20044002 来自浙江省

    这个量表用起来方便

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2142249, encodeId=615d2142249b5, content=这个量表用起来方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22b81526605, createdName=wyh20044002, createdTime=Sun Jun 11 20:57:08 CST 2023, time=2023-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=379039, encodeId=b2ba3e903992, content=学习学习,感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a675276231, createdName=14832c09m20暂无昵称, createdTime=Sun Feb 09 00:10:51 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379038, encodeId=4b7d3e90389c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a675276231, createdName=14832c09m20暂无昵称, createdTime=Sun Feb 09 00:10:35 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360128, encodeId=60b2360128ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/3ca7e45a5a3a70cdf0a44fb6301db4ff.jpg, createdBy=aa512256377, createdName=121757d6m64(暂无昵称), createdTime=Thu Feb 07 12:36:47 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318706, encodeId=a376318e0656, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat May 26 09:39:46 CST 2018, time=2018-05-26, status=1, ipAttribution=)]
    2020-02-09 14832c09m20暂无昵称

    学习学习,感谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2142249, encodeId=615d2142249b5, content=这个量表用起来方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22b81526605, createdName=wyh20044002, createdTime=Sun Jun 11 20:57:08 CST 2023, time=2023-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=379039, encodeId=b2ba3e903992, content=学习学习,感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a675276231, createdName=14832c09m20暂无昵称, createdTime=Sun Feb 09 00:10:51 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379038, encodeId=4b7d3e90389c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a675276231, createdName=14832c09m20暂无昵称, createdTime=Sun Feb 09 00:10:35 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360128, encodeId=60b2360128ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/3ca7e45a5a3a70cdf0a44fb6301db4ff.jpg, createdBy=aa512256377, createdName=121757d6m64(暂无昵称), createdTime=Thu Feb 07 12:36:47 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318706, encodeId=a376318e0656, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat May 26 09:39:46 CST 2018, time=2018-05-26, status=1, ipAttribution=)]
    2020-02-09 14832c09m20暂无昵称

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2142249, encodeId=615d2142249b5, content=这个量表用起来方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22b81526605, createdName=wyh20044002, createdTime=Sun Jun 11 20:57:08 CST 2023, time=2023-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=379039, encodeId=b2ba3e903992, content=学习学习,感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a675276231, createdName=14832c09m20暂无昵称, createdTime=Sun Feb 09 00:10:51 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379038, encodeId=4b7d3e90389c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a675276231, createdName=14832c09m20暂无昵称, createdTime=Sun Feb 09 00:10:35 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360128, encodeId=60b2360128ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/3ca7e45a5a3a70cdf0a44fb6301db4ff.jpg, createdBy=aa512256377, createdName=121757d6m64(暂无昵称), createdTime=Thu Feb 07 12:36:47 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318706, encodeId=a376318e0656, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat May 26 09:39:46 CST 2018, time=2018-05-26, status=1, ipAttribution=)]
    2019-02-07 121757d6m64(暂无昵称)

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2142249, encodeId=615d2142249b5, content=这个量表用起来方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22b81526605, createdName=wyh20044002, createdTime=Sun Jun 11 20:57:08 CST 2023, time=2023-06-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=379039, encodeId=b2ba3e903992, content=学习学习,感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a675276231, createdName=14832c09m20暂无昵称, createdTime=Sun Feb 09 00:10:51 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379038, encodeId=4b7d3e90389c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a675276231, createdName=14832c09m20暂无昵称, createdTime=Sun Feb 09 00:10:35 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360128, encodeId=60b2360128ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/3ca7e45a5a3a70cdf0a44fb6301db4ff.jpg, createdBy=aa512256377, createdName=121757d6m64(暂无昵称), createdTime=Thu Feb 07 12:36:47 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318706, encodeId=a376318e0656, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sat May 26 09:39:46 CST 2018, time=2018-05-26, status=1, ipAttribution=)]
    2018-05-26 龙胆草

    学习谢谢分享

    0